Vaccine for Eliminating Breast Cancer Developed by U.S
An effective vaccine has been developed by the scientists of America, which can prevent the development of breast cancer in mice. The researchers are now planning to conduct trials of the drug in humans.
The warning has been given by the researchers that it could be some years before the vaccine is widely available. The immunologist who led the research says the vaccine targets a protein found in most breast tumors.
Vincent Tuohy, from the Cleveland Clinic Lerner Research Institute, said "We believe that this vaccine will someday be used to prevent breast cancer in adult women in the same way that vaccines have prevented many childhood diseases".
If this vaccine works in humans the way it works in mice then it will be monumental. It would be able to eliminate breast cancer and save the lives of millions of women.
In the study, genetically cancer-prone mice were vaccinated half with a vaccine containing a-lactalbumin and half with a vaccine that did not contain the antigen. None of the mice vaccinated with a-lactalbumin developed breast cancer, while all of the other mice did.
Two cancer prevention vaccines have been approved by the U. S, one against cervical cancer and one against liver cancer. However, these vaccines target viruses the human papillomavirus (HPV) and the Hepatitis B virus (HBV) not cancer formation itself.
New Zealand News
- First deliveries of all-electric Porsche in Australia to take place this weekend
- Crown Resorts suffers record six-month loss due to COVID-19 closures
- Australia’s Crown Resorts 'not suitable' for Sydney gaming license: Inquiry Commission
- What Does Phasing Out Cheques Tell Us About Finance in New Zealand?
- South Korean casino operator GKL closes third casino amid soaring cases of COVID-19